The intent of the items in this section is to record the number of days, during the last 7 days (or since admission/reentry if less than 7 days) that any type of injection (subcutaneous, intramuscular or intradermal), insulin, and/or select medications were received by the resident. This section also includes an antipsychotic medication review that addresses gradual dose reductions (GDRs).
Note: The content of this course has been updated to reflect RAI changes effective 10/1 /2023.
The intent of the items in this section is to record the number of days, during the last 7 days (or since admission/reentry if less than 7 days) that any type of injection (subcutaneous, intramuscular or intradermal), insulin, and/or select medications were received by the resident. This section also includes an antipsychotic medication review that addresses gradual dose reductions (GDRs). Note: The content of this course has been updated to reflect RAI changes effective 10/1 /2023.
In support of improving patient care, Relias LLC is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
Arkansas State Board Of Nursing Approved Continuing Education program (CEBroker Provider #50-290).
District of Columbia Board of Nursing Approved Continuing Education program (CEBroker Provider #50-290).
Georgia Board of Nursing (CEBroker Provider #50-290)
Kentucky Board of Nursing (CEBroker Provider #50-290)
Nurses will receive 0.75 contact hours for participating in this course.
Mississippi Board of Nursing (CEBroker Provider #50-290)
New Mexico Board of Nursing (CEBroker Provider #50-290)
North Dakota Board of Nursing (CEBroker Provider #50-290)
South Carolina Board of Nursing (CEBroker Provider #50-290)
Outline:
Section 4: N0415 – High-Risk Drug Classes: Use and Indication
Section 5: N0450 – Antipsychotic Medication Review
Section 6: N2001 – Drug Regimen Review
Section 7: N2003 – Medication Follow-Up (Admission)
Section 8: N2005 – Medication Intervention (Discharge)
Reviewer: Laura Anderson, MSN RN, WCCRon Orth obtained a nursing degree from Milwaukee Area Technical College in 1985 and a B. A. in Health Care Administration from Concordia University in 1996. Mr. Orth possesses over 30 years of nursing experience with over 20 of those in the Skilled Nursing industry. Mr. Orth has extensive experience in teaching Medicare regulations to healthcare providers both in the US and internationally. Mr. Orth is currently the Director of Curriculum Design for the Acute and Post-acute Care verticals at Relias. Ron has also successfully completed the Infection Control Officer training through the AHCA.
Laura Anderson is currently a Curriculum Designer for Post-Acute Care at Relias and manages a team of subject matter expert writers. Previously, she was a Director of Nursing, Clinical Informatics Nurse, Senior Clinical Consultant, Nurse Auditor, Business Office Manager, Clinical Author, and Wound Care Nurse. Laura has dedicated more than 20 years of professional practice to the skilled nursing and long-term care industry. After receiving her Masters of Science in nursing with an emphasis in geriatrics, mental health, and education from the University of Wisconsin-Madison, she continued to pursue additional training in wound care. Laura is passionate about providing quality, resident-centered care that encompasses the whole person.
Access to over 1,450 courses! Access to 1,450+ courses for one low price.